These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2223406)

  • 1. Malignant melanoma.
    Smyth JF
    Cancer Chemother Biol Response Modif; 1990; 11():531-43. PubMed ID: 2223406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma.
    Smyth JF
    Cancer Chemother Biol Response Modif; 1992; 13():588-99. PubMed ID: 1389921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical therapy of malignant melanoma].
    Mini E; Periti P
    Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant melanoma--prognosis and actual treatment strategies with chemotherapy and biological response modifiers.
    Bergmann L
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 3():S31-6. PubMed ID: 2697576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic options in the medical management of advanced melanoma.
    Lutzky J
    Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma.
    Smyth JF
    Cancer Chemother Biol Response Modif; 1991; 12():591-602. PubMed ID: 1718379
    [No Abstract]   [Full Text] [Related]  

  • 8. [The latest diagnostical methods and therapy in melanoma].
    Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
    Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III adjuvant studies in operable malignant melanoma (review).
    Lejeune FJ
    Anticancer Res; 1987; 7(4B):701-5. PubMed ID: 3314671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment approaches for advanced cutaneous melanoma.
    Stein JA; Brownell I
    J Drugs Dermatol; 2008 Feb; 7(2):175-9. PubMed ID: 18335655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
    Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
    Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant melanoma.
    Schwartsmann G; Parkinson DR
    Cancer Chemother Biol Response Modif; 1993; 14():577-93. PubMed ID: 8312120
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of radiotherapy and hyperthermia in the management of malignant melanoma.
    Schmidt-Ullrich RK; Johnson CR
    Semin Surg Oncol; 1996; 12(6):407-15. PubMed ID: 8914205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatment of malignant melanoma.
    Mota A; Deisseroth A
    Clin Plast Surg; 2000 Jul; 27(3):463-74, x. PubMed ID: 10941566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma--new developments in diagnosis and therapy.
    Schneeberger A; Wagner SN
    Cancer Chemother Biol Response Modif; 2003; 21():609-36. PubMed ID: 15338766
    [No Abstract]   [Full Text] [Related]  

  • 17. Multimodality management of brain metastases in metastatic melanoma patients.
    Samlowski WE; Jensen RL; Shrieve DC
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1699-705. PubMed ID: 18062744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of biological response modifiers to enhance the action of Rituximab.
    Taylor RP
    Leuk Res; 2005 Jun; 29(6):599-600. PubMed ID: 15863194
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibody therapy of cancer.
    Weiner LM
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):43-51. PubMed ID: 10561017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.